Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Nephropathy toxic? 41 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Nephropathy toxic have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.1% of all adverse event reports for AMLODIPINE.

41
Reports of Nephropathy toxic with AMLODIPINE
0.1%
of all AMLODIPINE reports
1
Deaths
23
Hospitalizations

How Dangerous Is Nephropathy toxic From AMLODIPINE?

Of the 41 reports, 1 (2.4%) resulted in death, 23 (56.1%) required hospitalization, and 4 (9.8%) were considered life-threatening.

Is Nephropathy toxic Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 41 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Nephropathy toxic?

TACROLIMUS (913) VANCOMYCIN (684) CYCLOSPORINE (658) METHOTREXATE (567) CISPLATIN (539) CYCLOPHOSPHAMIDE (443) MYCOPHENOLATE MOFETIL (412) PREDNISONE (364) RITUXIMAB (341) ETOPOSIDE (323)

Which AMLODIPINE Alternatives Have Lower Nephropathy toxic Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Nephropathy toxic Reports All Drugs Causing Nephropathy toxic AMLODIPINE Demographics